General Information of the Compound
Compound ID
CP0911851
Compound Name
1-(2-(piperidin-1-yl)ethyl)-4-(2-(trifluoromethyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C19H20F3N5
Molecular Weight
375.398
Canonical SMILES
FC(F)(F)c1ccccc1-c1ncnc2c1cnn2CCN1CCCCC1
    Show/Hide
InChI
InChI=1S/C19H20F3N5/c20-19(21,22)16-7-3-2-6-14(16)17-15-12-25-27(18(15)24-13-23-17)11-10-26-8-4-1-5-9-26/h2-3,6-7,12-13H,1,4-5,8-11H2
    Show/Hide
InChIKey
USDYUJSBNNBGIO-UHFFFAOYSA-N
Physicochemical Property
logP
3.998
Rotatable Bonds
4
Heavy Atom Count
27
Polar Areas
46.84
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 74767366
ChEMBL ID
CHEMBL4292753
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 125 nM
   TI
   LI
   LO
   TS